Replies to post #2186 on Idenix Pharmaceuticals (IDIX)

[DewDiligence]

3Q07 Tyzeka sales in the US were $1.7M, up from $1.0M in 2Q07. NVS books sales outside the US and has not disclosed the 3Q07 number.

Beginning in 4Q07, IDIX will no longer report US sales of Tyzeka due to the restructuring of the Tyzeka/Sebivo collaboration with NVS into a royalty arrangement.